GLP-1 warning letters to a firm of this name
Matched by name; FDA’s letter gives the address it was sent to.
GLP-1 recalls by a firm of this name
- Class II, ongoing, reported Oct 15, 2025Lack of Assurance of SterilityD-0083-2026 · Semaglutide with B12 for Injection, all strengths and presentations, GenoGenix, LLC, 2840 NW 2nd Ave Ste 204 Boca Raton,...
- Class II, ongoing, reported Oct 15, 2025Lack of Assurance of SterilityD-0091-2026 · Semaglutide for Injection, a) 20 mg b) 20 mg/mL, 10 mL Multi-Dose Vials, GenoGenix, LLC, 2840 NW 2nd Ave Ste 204 Boca Ra...
- Class II, ongoing, reported Oct 15, 2025Lack of Assurance of SterilityD-0092-2026 · Tirzepatide, 60mg/10 mL for Injection, 10mL vial lyophilized, all presentations, GenoGenix, LLC, 2840 NW 2nd Ave Ste 204...
Matched by name, from FDA’s enforcement reports (updated by FDA Sep 30, 2026). Every GLP-1 recall
Source
Copied from FDA’s Registered Outsourcing Facilities table ↗, updated by FDA Sep 30, 2026, read Oct 7, 2026. The table does not include State Board of Pharmacy actions. All 98 registered facilities



